U.S. Markets closed

Repros Therapeutics Inc. (RPRX)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.52-0.02 (-3.48%)
At close: 4:00PM EDT
People also watch
SNSSTHLDCYCCOPXAOGXI
Interactive chart
Previous Close0.54
Open0.57
Bid0.52 x 1200
Ask0.68 x 5000
Day's Range0.52 - 0.57
52 Week Range0.51 - 2.48
Volume212,645
Avg. Volume152,592
Market Cap15.34M
Beta0.61
PE Ratio (TTM)-0.74
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Associated Press18 days ago

    Repros Therapeutics reports 1Q loss

    On a per-share basis, the The Woodlands, Texas-based company said it had a loss of 22 cents. The biopharmaceutical company posted revenue of $7,000 in the period. In the final minutes of trading on Tuesday, ...

  • What's in the Cards for Repros (RPRX) this Earnings Season?
    Zacks22 days ago

    What's in the Cards for Repros (RPRX) this Earnings Season?

    Repros Therapeutics Inc. (RPRX) is expected to report first-quarter 2017 results this month. Let's see how things are shaping up for this quarter.

  • Repros' Proellex Continues to be Under Partial Clinical Hold
    Zacks2 months ago

    Repros' Proellex Continues to be Under Partial Clinical Hold

    Repros Therapeutics (RPRX) announced that the FDA will continue to maintain partial clinical hold on its pipeline candidate Proellex for uterine fibroids indication as the agency internally reviews data related to the effect of the same on the liver